` Comparison: 42C, NOVO B - Alpha Spread

I
42C
vs
NOVO B

Over the past 12 months, 42C has outperformed NOVO B, delivering a return of -31% compared to the NOVO B's 49% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
42C
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

I
42C Intrinsic Value
0.03 SGD
Undervaluation 34%
Intrinsic Value
Price
NOVO B Intrinsic Value
644.98 DKK
Undervaluation 30%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
I
IX Biopharma Ltd
SGX:42C
0.02 SGD
Novo Nordisk A/S
CSE:NOVO B
452.1 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
42C, NOVO B

42C
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
I
IX Biopharma Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
42C, NOVO B

42C
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
I
IX Biopharma Ltd
SGX:42C
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

42C
18.4%
NOVO B
84.3%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

Operating Margin

42C
-102%
NOVO B
44.6%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

Net Margin

42C
-138.8%
NOVO B
34.5%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

FCF Margin

42C
-82.4%
NOVO B
24.5%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

ROE

42C
-173.9%
NOVO B
88.1%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

ROA

42C
-61.9%
NOVO B
26.6%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

ROIC

42C
-83.2%
NOVO B
30.4%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

ROCE

42C
-83.1%
NOVO B
70%
LTM 3Y Avg 5Y Avg 10Y Avg
I
IX Biopharma Ltd
Novo Nordisk A/S

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
42C, NOVO B

Loading

Performance Gap
42C, NOVO B

Loading
42C
NOVO B
Difference
www.alphaspread.com

Performance By Year
42C, NOVO B

Loading
42C
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 42C to other stocks
Unlock Full Access to Alpha Spread
Create Free Account